PCAS - 2016 Q1 Sales: SHARP GROWTH IN NET SALES AGAIN

20 april 2016

SHARP GROWTH IN NET SALES AGAIN

Longjumeau, April 20, 2016

PCAS (Euronext Paris: PCA) , a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales for the 1 ^st quarter of 2016.

The PCAS Group's consolidated net sales totaled €45.3 million in the 1 ^st quarter of 2016, up by 12.2 % compared to the same period in the previous financial year (+10.2 % at constant exchange rate).

in millions of euros		2016		2015		% change		2016 At a constant exchange rate		% change
Net sales at 31 march		45.3		40.4		12.2 %		44.5		10.2 %
Pharmaceutical Synthesis		30.2		25.7		17.5 %		29.5		14.6 %
Fine specialty chemicals		15.1		14.6		2.9 %		15.0		2.4 %

Pharmaceutical Synthesis

Pharmaceutical synthesis activities in Health generated €30.2 million, up 17.5 % compared to 2015 (+14.6 % at constant exchange rate), particularly sustained by the Exclusive activity.

Fine specialty chemicals

Net sales of Fine Specialty Chemicals amounted to €15.1 million, up 2.9 % compared to 2015 (+2.4 % at a constant exchange rate), this activity growing both in Performance Additives and Advanced Specialty Chemicals.

Outlook for the current year

The company thus confirms its sales growth targets for 2016 as a whole, excluding growth through acquisition, both in Pharmaceutical Synthesis and in Fine Specialty Chemicals.

About PCAS 
PCAS specialises in the development and production of complex molecules for Life Sciences and Innovative Technologies. With 7% of its turnover dedicated to R&D and a wide international presence, PCAS is the preferred industrial partner of market-leading major global groups. The company offers a growing range of proprietary products and solutions in leading-edge segments, and also includes two subsidiaries with very strong potential: Protéus in biotechnology and Enersens in high-performance insulation. With a particularly high standard of performance, PCAS achieved net sales of €179.1 million in 2015 and employs nearly 900 people in six countries.
For more information about PCAS : www.pcas.com

PCAS	NewCap
Vincent Touraille / Eric Moissenot PCAS	Emmanuel Huynh / Louis-Victor Delouvrier NewCap Financial Communication & investors relations
Tel. : +33 1 69 79 61 32 www.pcas.com	Tel. : +33 1 44 71 98 53 pcas@newcap.eu

---